APPLY FOR FUNDING
The Bio/Med Investor Network works with promising U.S. based companies that have the potential to attract institutional capital in follow-on rounds. Our preference is to fund biotech, medtech and other healthcare companies that are past the prototype/proof of concept stage and are close to having customers or customer partnerships.
Bio/Med helps entrepreneurs prepare for the fundraising process by introducing them to angel investors and advisors, many of whom are successful entrepreneurs themselves. Our process is to review projects and select promising deals for initial screening by knowledgeable members. Those that pass the screening process will be invited to present at a member meeting where the members will vote on taking the project to due diligence.
NOTE: At this time, the Bio/Med Investor Network is only considering applications from U.S. based companies.
NOTE: We are in the process of establishing a seed fund, and are not currently investing as a Network. Feel free to submit your application, and we will consider via the fund when in place. Estimated launch April/May 2021.
Application and Funding Process
Web Application: Complete the online application and upload an executive summary and other documents through Gust.
Initial Review: Members perform an initial screening of the application to ensure it is within our scope of interest.
Screening: Screening team typically selects up to 6 companies per cycle (quarterly) to present via Zoom for further consideration.
Selection: Screening team selects 2-4 companies per cycle to present to full membership (currently via Zoom).
Present at Member Investment Meeting: Selected companies must give a PowerPoint or equivalent presentation of no more than 10 minutes in length, followed by a 10 minute Q&A period.
Due Diligence: Due diligence may take 30-60 days depending on the complexity of the deal. Companies with existing diligence reports available from other networks are encouraged to apply, resulting in an expedited decision by the Bio/Med members.